SERPINA12
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
serpin family A member 12 | MIM:617471 | Ensembl:ENSG00000165953 | HGNC:HGNC:18359 | PA134863157 | 14q32.13 |
GO terms in SERPINA12
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IBA | GO:0004867 | serine-type endopeptidase inhibitor activity |
BP | IBA | GO:0010951 | negative regulation of endopeptidase activity |
BP | IEA | GO:0010951 | negative regulation of endopeptidase activity |
BP | IEA | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling |
BP | IEA | GO:0045721 | negative regulation of gluconeogenesis |
BP | IEA | GO:0046628 | positive regulation of insulin receptor signaling pathway |
BP | IEA | GO:0051055 | negative regulation of lipid biosynthetic process |
BP | IEA | GO:0090181 | regulation of cholesterol metabolic process |
BP | IEA | GO:0090207 | regulation of triglyceride metabolic process |
CC | IBA | GO:0005615 | extracellular space |
CC | IEA | GO:0005886 | plasma membrane |
Gene expression in normal tissue: SERPINA12
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in SERPINA12
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD144 | NSC95397 | 3 |
iGMDRD123 | Isoevodiamine | 3 |
iGMDRD394 | BX-795 | 1 |
iGMDRD945 | ML214 | 6 |
iGMDRD883 | CIL55A | 4 |
iGMDRD193 | Fqi1 | 6 |
iGMDRD698 | Neratinib | 3 |
iGMDRD289 | Parthenolide | 3 |
iGMDRD105 | Triptolide | 3 |
iGMDRD121 | GMX1778 | 3 |
iGMDRD138 | PX 12 | 6 |
iGMDRD251 | ML162 | 6 |
iGMDRD260 | FQI-2 | 3 |
iGMDRD64 | Parbendazole | 6 |
iGMDRD246 | NPC26 | 3 |
iGMDRD188 | Piperlongumine | 3 |
iGMDRD577 | BIX01294 | 3 |
iGMDRD329 | Merck60 | 6 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in SERPINA12